PCSK9 inhibitors

2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
Wed, 09/2/15 - 12:34 pm
PCSK9 inhibitors
insurers
Regeneron
Sanofi
Amgen
Praluent
Repatha
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Repatha
Amgen
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?
Bidness, ETC
Mon, 08/31/15 - 11:13 am
PCSK9 inhibitors
Amgen
Regeneron
Repatha
Praluent
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Bizjournals.com
Sun, 08/30/15 - 02:04 pm
Alnylam
Amgen
The Medicines Company
PCSK9 inhibitors
ALN-PCSsc
Repatha
Praluent
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
drug pricing
Repatha
Praluent
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
FDA approves Amgen's cholesterol drug Repatha
Yahoo/Reuters
Thu, 08/27/15 - 05:29 pm
FDA
Amgen
Repatha
PCSK9 inhibitors
Payers Set To Play Hardball On PCSK9 Pricing
Investors.com
Fri, 08/14/15 - 11:22 am
payer negotiation
drug pricing
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
hepatitis C
Express Scripts
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
CVS
PCSK9 inhibitors
formulary
Sanofi
Regeneron
Praluent
Amgen
Repatha
Sanofi draws a $14,600 line in the sand for Praluent payer fight
Fierce Pharma Marketing
Tue, 07/28/15 - 10:22 am
Sanofi
Praluent
Repatha
Amgen
Regeneron
drug pricing
PCSK9 inhibitors
Docs are Excited About Prescribing Those New Cholesterol Drugs: Survey
WSJ Pharmalot
Fri, 07/24/15 - 03:47 pm
physicians
PCSK9 inhibitors
Praluent
Repatha
Amgen
Sanofi
Regeneron
Sanofi's big new cholesterol drug wins European green light
Yahoo/Reuters
Fri, 07/24/15 - 10:05 am
Praluent
Sanofi
Regeneron
Europe
PCSK9 inhibitors
Amgen
Repatha
Praluent's FDA review looms, but questions persist
Medical Marketing and Media
Wed, 07/22/15 - 09:45 pm
Praluent
FDA
PCSK9 inhibitors
Sanofi
Regeneron
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
Sanofi cholesterol drug, GSK malaria shot may get EU okay Friday
Yahoo/Reuters
Tue, 07/21/15 - 10:30 am
GSK
Sanofi
Europe
Praluent
malaria
PCSK9 inhibitors
Repatha
Amgen
Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Bloomberg
Tue, 07/21/15 - 10:11 am
Amgen
Europe
PCSK9 inhibitors
Repatha
An interview with Sanofi's president of North American pharma
BioPharma Dive
Wed, 06/24/15 - 01:22 pm
Sanofi
diabetes
PCSK9 inhibitors
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Amgen
Sanofi
Regeneron
Repatha
Praluent
PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Amgen
Regeneron
Sanofi
Repatha
Praluent
FDA
advisory panels
PCSK9 inhibitors

Pages